1Bloomgarden ZT. Treatment issues in type 1 diabetes[J]. Diabetes Care, 2002,25:230-236. 被引量：1
2Masharani U, Karam JH. Pancreatic hormones and diabetes mellitus. In: Greenspan FS, Gardner DG eds. Basic and Clinical Endocrinology[M]. 6th edition. 北京: 人民卫生出版社, 2001.623-698. 被引量：1
3Rosenstock J, Riddle M, Dailey G, et al. Treatment to target study: feasibility of achieving control with the addition of basal bedtime insulin glargine (Lantus) or NPH insulin in insulin-naive patients with type 2 diabetes on oral agents[J]. Diabetes, 2001,50(Suppl 2):A129. 被引量：1
4American Diabetes Association. Insulin administration[J]. Diabetes Care, 2002,25(Suppl 1):S112-S115. 被引量：1
6nger J,Fredrichson L. Apriner on intensive diabetes mangagement and insulin pupm therag[J]. Prinary Care Rep, 1997,3:9-18. 被引量：1
7Reynolds NA,Wagstaff AJ. Insulin asport a review of its use in the management of type 1 or 2 diabetes me Hitus[J]. Drugs, 2004,64 (17) : 1957- 1974. 被引量：1
8IlkovaH,Glaser B,Tunckale A,et al. Indnetion of Longtemglycem ic control in nemly diagnosel type 2 diabetespatients by transient intensive insulin treatment[J]. Diabetes Care, 1997,20:1353-1356. 被引量：1
9Colquitt JL, Green C, Sidhu MK, et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes[J]. Health Technol Assess, 2004, 8(43) :1-17. 被引量：1
10Reynolds NA, Wagstaff AJ. Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus[J]. Drugs,2004,64( 17 ) : 1957-1974. 被引量：1
